>
Switch to:

Cullinan Oncology Equity-to-Asset

: -0.41 (As of Dec. 2019)
View and export this data going back to 2021. Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cullinan Oncology's Total Stockholders Equity for the quarter that ended in Dec. 2019 was $-40.77 Mil. Cullinan Oncology's Total Assets for the quarter that ended in Dec. 2019 was $100.46 Mil.

The historical rank and industry rank for Cullinan Oncology's Equity-to-Asset or its related term are showing as below:


Cullinan Oncology Equity-to-Asset Historical Data

The historical data trend for Cullinan Oncology's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cullinan Oncology Annual Data
Trend Dec18 Dec19 Dec20
Equity-to-Asset
-0.60 -0.41 -0.36

Cullinan Oncology Semi-Annual Data
Dec18 Dec19 Dec20
Equity-to-Asset -0.60 -0.41 -0.36

Competitive Comparison

For the Biotechnology subindustry, Cullinan Oncology's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Cullinan Oncology Equity-to-Asset Distribution

For the Biotechnology industry and Healthcare sector, Cullinan Oncology's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cullinan Oncology's Equity-to-Asset falls into.



Cullinan Oncology Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cullinan Oncology's Equity to Asset Ratio for the fiscal year that ended in Dec. 2019 is calculated as

Equity to Asset (A: Dec. 2019 )=Total Stockholders Equity/Total Assets
=-40.773/100.461
=

Cullinan Oncology's Equity to Asset Ratio for the quarter that ended in Dec. 2019 is calculated as

Equity to Asset (Q: Dec. 2019 )=Total Stockholders Equity/Total Assets
=-40.773/100.461
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cullinan Oncology  (NAS:CGEM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cullinan Oncology Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cullinan Oncology's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cullinan Oncology Business Description

Cullinan Oncology logo
Industry
Healthcare » Biotechnology NAICS : 541713 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
One Main Street, Suite 520, Cambridge, MA, USA, 02142
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Cullinan Oncology Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)